Macy’s Beats Q2 Estimates and Raises Guidance, but Shares Slip on Cautious Outlook and Mixed Beat Quality
Premarket weakness reflects tariff refunds, soft core sales, and cautious Q3 EPS.
Premarket weakness reflects tariff refunds, soft core sales, and cautious Q3 EPS.
Morgan Stanley likes Macy’s on recovery hopes but is cautious on Lululemon due to growth and competition risks.
Macy’s reported its strongest first quarter in years, with comparable sales up 3% and Bloomingdale’s surging 10.2%. The retailer raised its full-year 2026 sales and earnings guidance for the first time in nearly four years.
Berkshire bought a $2.6B stake in Delta again and also took a small new position in Macy’s while reshaping its portfolio in Q1 2026.
Macy’s exceeded its Q4 and full-year 2025 guidance, with comparable sales up 1.8% and record holiday performance at Bloomingdale’s. Shares jumped as tariff pressures are expected to ease in the second half of 2026.
Macy's posts best comparable sales growth in 3+ years with 3.2% increase. Management remains "highly cautious" about the holiday spending outlook.